Nuveen Asset Management, LLC Mirum Pharmaceuticals, Inc. Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 407,119 shares of MIRM stock, worth $15.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

407,119

Previous 311,185 30.83%

Holding current value

$15.9 Million

Previous $7.82 Million 78.08%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$23.57 - $34.85 $2.26 Million - $3.34 Million	95,934 Added 30.83%	407,119 $13.9 Million
Q1 2024 May 13, 2024	SELL	$24.92 - $30.02 $3.97 Million - $4.78 Million	-159,155 Reduced 33.84%	311,185 $7.82 Million
Q4 2023 Feb 14, 2024	BUY	$27.14 - $34.93 $1.02 Million - $1.31 Million	37,557 Added 8.68%	470,340 $13.9 Million
Q3 2023 Nov 14, 2023	BUY	$24.63 - $32.85 $8.8 Million - $11.7 Million	357,183 Added 472.46%	432,783 $13.7 Million
Q2 2023 Aug 14, 2023	BUY	$23.51 - $30.09 $91,830 - $117,531	3,906 Added 5.45%	75,600 $1.96 Million
Q1 2023 May 15, 2023	SELL	$19.19 - $24.1 $29,821 - $37,451	-1,554 Reduced 2.12%	71,694 $1.72 Million
Q4 2022 Feb 14, 2023	SELL	$17.59 - $23.83 $184,642 - $250,143	-10,497 Reduced 12.53%	73,248 $1.43 Million
Q3 2022 Nov 14, 2022	BUY	$19.98 - $29.44 $897,941 - $1.32 Million	44,942 Added 115.82%	83,745 $1.76 Million
Q2 2022 Aug 15, 2022	SELL	$18.42 - $27.5 $676,971 - $1.01 Million	-36,752 Reduced 48.64%	38,803 $756,000
Q1 2022 May 16, 2022	BUY	$15.5 - $23.93 $1 Million - $1.54 Million	64,535 Added 585.62%	75,555 $1.67 Million
Q2 2021 Aug 16, 2021	SELL	$15.84 - $20.6 $52,272 - $67,980	-3,300 Reduced 23.04%	11,020 $191,000
Q1 2021 May 17, 2021	SELL	$16.29 - $21.92 $170,898 - $229,962	-10,491 Reduced 42.28%	14,320 $284,000
Q4 2020 Feb 16, 2021	SELL	$15.75 - $25.45 $2,126 - $3,435	-135 Reduced 0.54%	24,811 $433,000
Q3 2020 Nov 16, 2020	BUY	$18.4 - $26.59 $267,720 - $386,884	14,550 Added 139.96%	24,946 $481,000
Q2 2020 Aug 14, 2020	BUY	$11.51 - $20.97 $119,657 - $218,004	10,396 New	10,396 $202,000

Others Institutions Holding MIRM

# of Institutions

172

Shares Held

54.2M

Call Options Held

96.1K

Put Options Held

54.8K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.43B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Mirum Pharmaceuticals, Inc. Transaction History